|
|
||||||||
1 Department of Neuroscience, University of Florida McKnight Brain Institute and College of Medicine
2 Department of Physiology and Functional Genomics, University of Florida McKnight Brain Institute and College of Medicine
3 Department of Pharmacodynamics, University of Florida College of Pharmacy, Gainesville, Florida 32610
4 Department of Physiology, University of Bristol School of Medical Sciences, Bristol BS8 1TD, United Kingdom
The aim of this study was to develop an efficient method for packaging and concentrating lentiviral vectors that consistently yields high-titer virus on a scale suitable for in vivo applications. Transient cotransfection of 293T packaging cells with DNA plasmids encoding lentiviral vector components was optimized using SuperFect, an activated dendrimer-based transfection reagent. The use of SuperFect allowed reproducible and efficient production of high-titer lentiviral vector at concentrations greater than 1 x 107 transducing units per ml (TU/ml) and required less than one-third of the total amount of DNA used in traditional calcium phosphate transfection methods. Viral titers were further increased using a novel concentration protocol that yielded an average final titer of 1.4 x 1010 TU/ml. Lentiviruses produced using these methods exhibited efficient transduction of central nervous system and peripheral tissues in vivo. The method is reproducible and can be scaled up to facilitate the use of these vectors in animal studies.
cardiomyocytes; in vivo gene delivery; neurons; retina; transfection
This article has been cited by other articles:
![]() |
S. A. Byron, M. G. Gartside, C. L. Wellens, M. A. Mallon, J. B. Keenan, M. A. Powell, P. J. Goodfellow, and P. M. Pollock Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation Cancer Res., September 1, 2008; 68(17): 6902 - 6907. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Der Sarkissian, J. L. Grobe, L. Yuan, D. R. Narielwala, G. A. Walter, M. J. Katovich, and M. K. Raizada Cardiac Overexpression of Angiotensin Converting Enzyme 2 Protects the Heart From Ischemia-Induced Pathophysiology Hypertension, March 1, 2008; 51(3): 712 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamazato, Y. Yamazato, C. Sun, C. Diez-Freire, and M. K. Raizada Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Causes Long-Term Decrease in Blood Pressure in the Spontaneously Hypertensive Rats Hypertension, April 1, 2007; 49(4): 926 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Anderson, A. Semenov, J. H. Song, and K. A. Martemyanov The Membrane Anchor R7BP Controls the Proteolytic Stability of the Striatal Specific RGS Protein, RGS9-2 J. Biol. Chem., February 16, 2007; 282(7): 4772 - 4781. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Diez-Freire, J. Vazquez, M. F. Correa de Adjounian, M. F. R. Ferrari, L. Yuan, X. Silver, R. Torres, and M. K. Raizada ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR Physiol Genomics, January 12, 2007; 27(1): 12 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chan, D. Nesbeth, T. MacKey, J. Galea-Lauri, J. Gaken, F. Martin, M. Collins, G. Mufti, F. Farzaneh, and D. Darling Conjugation of Lentivirus to Paramagnetic Particles via Nonviral Proteins Allows Efficient Concentration and Infection of Primary Acute Myeloid Leukemia Cells J. Virol., October 15, 2005; 79(20): 13190 - 13194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Huentelman, J. L Grobe, J. Vazquez, J. M Stewart, A. P Mecca, M. J Katovich, C. M Ferrario, and M. K Raizada Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats Exp Physiol, September 1, 2005; 90(5): 783 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Falcon, S. J. Veerasingham, C. Sumners, and M. K. Raizada Angiotensin II Type 2 Receptor-Mediated Gene Expression Profiling in Human Coronary Artery Endothelial Cells Hypertension, April 1, 2005; 45(4): 692 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Duale, S. Kasparov, J. F. R. Paton, and A. G. Teschemacher Differences in transductional tropism of adenoviral and lentiviral vectors in the rat brainstem Exp Physiol, January 1, 2005; 90(1): 71 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Teschemacher, S. Wang, T. Lonergan, H. Duale, H. Waki, J. F. R. Paton, and S. Kasparov Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function Exp Physiol, January 1, 2005; 90(1): 61 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Falcon, J. M. Stewart, E. Bourassa, M. J. Katovich, G. Walter, R. C. Speth, C. Sumners, and M. K. Raizada Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension Physiol Genomics, November 17, 2004; 19(3): 255 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Metcalfe, M. J. Huentelman, L. D. Parilak, D. G. Taylor, M. J. Katovich, H. J. Knot, C. Sumners, and M. K. Raizada Prevention of Cardiac Hypertrophy by Angiotensin II Type-2 Receptor Gene Transfer Hypertension, June 1, 2004; 43(6): 1233 - 1238. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |